LXEO lexeotx.com: Bozor kapitallashuvining balans qiymatiga nisbati

Lexeo Therapeutics (LXEO) kompaniyasining rasmiy ramzlari

Lexeo Therapeutics (LXEO) uchun kirishning yuqori to'siqlari genetik materiallar transporti patentlari va dori sintezining murakkabligi tufayli yuzaga kelgan. Yurak terapiyasi ishlab chiqilishi iqtisodiy sikllardan mustaqil qolmoqda va 0.96 ko'rsatkichi bilan tasdiqlanganidek, buning o'rniga ilmiy yutuqlarga tayanadi. Kompaniyaning narxlar grafigi professional hamjamiyatda kuchli obro'ga ega bo'lgan, neyrodegenerativ patologiyalar sohasidagi istiqbolli ishtirokchining dinamikasini aks ettiradi.

lexeotx.com (LXEO): Kapitallashuvning balans qiymatiga nisbati 21.02.2024dan 28.10.2026gacha

LXEO (Lexeo Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi lexeotx.com|LXEO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Lexeo|LXEO - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Lexeo Therapeutics|LXEO - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati lexeotx.com|LXEO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Lexeo Therapeutics|LXEO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati lexeotx.com|LXEO - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Lexeo
Kompaniyaning asosiy tahlili:LXEO, Lexeo Therapeutics Inc.
Lexeo Therapeutics ishlab chiqargan mahsulot

Genetik dori vositalarini ishlab chiqishning ilk bosqichlari natijasida daromad yetishmasligi sababli, narx-kitob koeffitsiyenti Lexeo Therapeutics (LXEO) sof kapitaliga nisbatan bozorning spekulyativ premiumini aks ettiradi. Ushbu grafik bozor kapitalizatsiyasini aktivlarning kitob qiymati bilan solishtirib, kompaniyaning kelgusidagi muvaffaqiyatlari bo'yicha investorlar konsensusini namoyish etadi, garchi tekislangan qayta baholash trayektoriyasi salbiy kredit hodisalari yuz bergan taqdirda aktivlar qiymatini keskin kamaytirish xatarlarini yashirishi mumkin bo'lsa-da.

Raqobatchilar tahlili

Bozor qiymatining balans qiymatiga nisbati TEM|qiagen.com (QGEN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|BEAM - Bozor qiymatining balans qiymatiga nisbati|SRPT - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TWST|Bozor qiymatining balans qiymatiga koeffitsiyenti 10x|Kapitallashuvning sof aktivlarga nisbati Intellia Therapeutics (NTLA)|Kapitallashuvning balans qiymatiga nisbati stoketherapeutics.com|BioLife Solutions - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti WVE (Wave Life Sciences Ltd)|MAZE: Bozor qiymatining balans qiymatiga nisbati|SION - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Prime Medicine, Inc. (PRME)|tayshagtx.com (TSHA) - Balans qiymatiga nisbatan bozor qiymati|QURE - Kapitallashuvning sof aktivlarga nisbati|MeiraGTx Holdings (MGTX) - Bozor kapitallashuvining balans qiymatiga multiplikatori|RGNX - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Solid Corp|Ocugen, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti PACB (pacb.com)|Bozor qiymatining balans qiymatiga nisbati Benitec Biopharma|Balans qiymatiga nisbatan bozor qiymati Design Therapeutics Inc DSGN|Rocket Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|FDMT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati korrobio.com (KRRO)|editasmedicine.com (EDIT) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SLN (Silence Therapeutics plc)|Bozor qiymatining balans qiymatiga koeffitsiyenti ProQR Therapeutics NV (PRQR)|Kapitallashuvning sof aktivlarga nisbati CDXS|Bozor kapitallashuvining balans qiymatiga nisbati Sangamo BioSciences SGMO|Kapitallashuvning sof aktivlarga nisbati Nautilus Bio (NAUT)|Bozor kapitallashuvining balans qiymatiga multiplikatori metagenomi.co MGX|Bozor kapitallashuvining balans qiymatiga nisbati DTIL (Precision BioSciences)|GBIO - Balans qiymatiga nisbatan bozor kapitallashuvi|BOLD (Boundless Bio, Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|XCUR (Exicure) - Kapitallashuvning sof aktivlarga nisbati|IMNN: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PHIO|Bozor qiymatining balans qiymatiga nisbati Mustang Bio, Inc. (MBIO)|Bozor qiymatining balans qiymatiga nisbati transcodetherapeutics.com RNAZ|BNGO - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning balans qiymatiga nisbati Applied DNA Corp APDN|BLUE (bluebird bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|IPA: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati OMGA|Singular Genomics Systems, Inc. (OMIC) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Regulus Therapeutics Inc (RGLS)|Kapitallashuvning balans qiymatiga nisbati SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. TBIO|Kapitallashuvning balans qiymatiga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)